🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was conducted to evaluate the complete response rate of Ibrutini...
Status
Completed
Location
Samsung Medical Center
Start Date
2016-05-01
Trial ID
NCT02670616
Treatments Being Tested
This was an open-label, non-randomized, multicenter, Phase 2 study evaluati...
Status
Completed
Location
Moores Cancer Center at UC San Diego /ID# 128535
Start Date
2014-09-10
Trial ID
NCT02141282
Treatments Being Tested
The purpose of this study is to evaluate if ibrutinib administered in combi...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-03
Trial ID
NCT01855750
Treatments Being Tested
Background: \- Chronic lymphocytic leukemia and small lymphocytic lymphoma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-01-05
Trial ID
NCT01500733
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ibrutin...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-16
Trial ID
NCT01776840
Treatments Being Tested
This phase II trial studies how well ibrutinib and nivolumab work in treati...
Status
Active Not Recruiting
Location
Winship Cancer Center of Emory University
Start Date
2016-12-20
Trial ID
NCT02940301
Treatments Being Tested
The purpose of this study is to describe the effectiveness (overall respons...
Status
Completed
Location
Apollo Hospitals International Limited
Start Date
2018-04-28
Trial ID
NCT03476655
Treatments Being Tested
This phase Ib trials studies the side effects of daratumumab and ibrutinib ...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2018-08-16
Trial ID
NCT03447808
Treatments Being Tested
This phase IB/II trial tests the safety, side effects and effectiveness of ...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2025-05-29
Trial ID
NCT06357676
The purpose of this study is to evaluate the efficacy and safety of ibrutin...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-10
Trial ID
NCT01646021
Treatments Being Tested